Skip to main content
Signal8

Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

NASDAQ:VYGRHealthcare
-2.27%$1.72
AH$1.73+0.58%vs close
Mkt Cap$105.98M
Float50.31M
O/S61.62M
Vol
$ Vol
RVOL
Inst Own56.8%
SI7.2%
Earnings
Dilution
Financials Summary
Revenue$40.37M
Net Income-$119.72M
Total Assets$252.28M
Free Cash Flow-$135.06M
Debt & Equity
Debt 16%
Equity 84%
Total Debt$36.5M
Total Equity$196.08M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in VYGR's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$252.28M
Liabilities$56.2M
Accounts Receivable$1.76M
Accounts Payable$5.01M
Inventory$0
PP&E (Net)$41.61M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$40.37M$80M$250.01M$40.91M$37.41M$171.13M$104.39M$7.62M$10.13M$14.22M$17.33M$0$0
YoY Growth-49.5%-68.0%511.2%9.3%-78.1%63.9%1270.1%-24.8%-28.7%-18.0%---
Cost of Revenue$132.27M$0$92.17M$55.76M$73.79M$108.75M$119.73M$64.91M$62.26M$42.25M$27.68M$8.9M$4.63M
Gross Profit-$91.9M$80M$157.84M-$14.86M-$36.37M$62.38M-$15.34M-$57.29M-$52.13M-$28.03M-$10.35M-$8.9M-$4.63M
Gross Margin-227.6%100.0%63.1%-36.3%-97.2%36.4%-14.7%-751.9%-514.3%-197.1%-59.7%--
Research and Development$134.67M$127.37M$92.17M$60.76M$73.79M$108.75M$119.73M$64.91M$62.26M$42.25M$27.68M$8.9M$4.63M
Selling, General, and Administrative$36.44M$35.92M$35.82M$30.98M$37.25M$34.99M$36.34M$33.81M$19.74M$13.27M$9.91M$5.47M$2.9M
Other-$131.17M$0-$92.17M-$55.76M-$73.79M-$108.75M-$119.73M$2.63M$1.17M$1.16M-$9.42M$0$0
Total Operating Expenses$39.94M$163.29M$35.82M$35.98M$37.25M$34.99M$36.34M$98.71M$82M$55.52M$37.59M$14.37M$2.9M
Operating Income (EBIT)-$131.84M-$83.29M$122.01M-$50.84M-$73.62M$27.38M-$51.68M-$91.09M-$71.86M-$41.3M-$20.25M-$14.37M-$7.53M
Operating Margin-326.6%-104.1%48.8%-124.3%-196.8%16.0%-49.5%-1195.6%-709.1%-290.4%-116.8%--
Interest Expense$0$0$0$0$0$0$0$0$0$976K$332K$0$0
Interest Income$10.62M$18.33M$11.72M$1.79M$0$1.66M$6.46M$3.31M$1.23M$0$0$0$134K
Other Income (Expense)$12.27M$18.95M$11.72M$4.45M$2.42M$9.36M$8.08M$2.63M$1.17M$1.16M-$9.42M-$1.95M-$134K
Income Before Tax (EBT)-$119.58M-$64.34M$133.74M-$46.39M-$71.2M$36.74M-$43.6M-$88.47M-$70.7M-$40.14M-$29.67M-$16.32M-$7.67M
Income Tax Expense$144K$665K$1.41M$16K$0$0$0-$180K$0$52K$0$0$0
Net Income-$119.72M-$65M$132.33M-$46.41M-$71.2M$36.74M-$43.6M-$88.29M-$70.7M-$40.19M-$29.67M-$16.32M-$7.67M
Net Income Margin-296.5%-81.3%52.9%-113.4%-190.3%21.5%-41.8%-1158.8%-697.6%-282.7%-171.2%--
Supplementary Data
EPS-2.04-1.133.08-1.21-1.750.99-1.14-2.75-2.64-1.59-7.08-1.11-16.55
Diluted EPS-2.04-1.132.97-1.21-1.750.98-1.14-2.75-2.64-1.59-7.08-1.11-16.55
Weighted Average OS58.69M57.67M43.02M38.36M37.67M37.13M35.90M32.07M26.80M25.30M4.19M14.71M463,137
EBITDA-$115.52M-$59.61M$138.18M-$39.65M-$66.03M$31.2M-$48.91M-$88.98M-$70.27M-$40.69M-$19.65M-$14.18M$0
EBITDA Margin-286.1%-74.5%55.3%-96.9%-176.5%18.2%-46.9%-1167.8%-693.3%-286.1%-113.4%--
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$65.3M$71.37M$68.8M$98.96M$117.43M$104.44M$86.04M$46.86M$31.53M$36.64M$31.31M$7.04M$135K
Short-Term Investments$131.15M$195.32M$162.07M$19.89M$15.11M$76.7M$195.49M$108.95M$137.52M$137.78M$163.03M$0$0
Cash and Short-Term Investments$196.45M$266.68M$230.88M$118.85M$132.54M$181.14M$281.53M$155.81M$169.05M$174.42M$224.34M$7.04M$135K
Accounts Receivable$1.76M$4.49M$84.45M$639K$748K$8.01M$18.7M$201K$0$2.3M$411K$0$0
Inventory$0$0$0$0$0$0$2.2M$5.11M$1.85M$1.52M-$29.24M$0$0
Other Current Assets$4.48M$2.87M$2.63M$4.23M$1.7M$7.16M$1.95M$1.36M$2.22M$430K$382K$1.3M$0
Total Current Assets$202.69M$276.81M$319.68M$124.5M$136.7M$197.77M$304.66M$162.48M$171.79M$178.79M$195.89M$8.36M$135K
Long-Term Assets
Property, Plant & Equipment Net$41.61M$47.66M$30M$33.34M$55.38M$61.5M$46.46M$12.77M$10.28M$7.89M$3.23M$2.8M$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$65.7M$0$0$0$0$1.92M$628K$1.1M$1.36M$30.01M$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$7.98M$2.87M$1.59M$1.51M$1.78M$2.32M$1.72M$1.15M$1.3M$1.53M$321K$335K$14K
Total Long-Term Assets$49.59M$116.24M$31.6M$34.86M$57.16M$63.81M$50.1M$14.55M$12.69M$10.78M$33.56M$3.14M$14K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$252.28M$393.05M$351.28M$159.36M$193.85M$261.58M$354.76M$177.03M$184.48M$189.57M$229.46M$11.5M$149K
Liabilities
Current Liabilities
Accounts Payable$5.01M$4M$1.6M$2.57M$574K$634K$4.07M$1.04M$1.02M$550K$612K$1.55M$950K
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$2.93M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$1.59M$24.39M$42.88M$59.38M$33.89M$0$47.23M$20.85M$3.38M$6.76M$19.59M$0$0
Other Current Liabilities$9.09M$6.75M$6.61M$4.56M$5.02M$7.73M$15.78M$6.01M$8.11M$4.09M$2.39M$552K$15K
Total Current Liabilities$26.54M$49.79M$64.51M$72.59M$50.98M$26.77M$76.01M$31.67M$15.9M$13.8M$23.93M$2.47M$3.98M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$6.3M$0
Long-Term Unearned Revenue$0$6M$32.36M$6.45M$8.21M$0$194.49M$113.05M$31.56M$41.58M$54.98M$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0-$47.23M$0$0$0$0$0$0
Other Long-Term Liabilities$1M$1M$1M$1M$1M$37.09M$1M$6.71M$6.35M$5.02M$1.06M$1.57M$0
Total Long-Term Liabilities$29.66M$43.5M$50.45M$27.75M$47.82M$80.5M$179.24M$98.91M$34.53M$39.84M$36.45M$7.87M$3.88M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0-$3.88M
Total Liabilities$56.2M$93.29M$114.96M$100.34M$98.8M$107.26M$255.25M$130.58M$50.43M$53.64M$60.38M$10.35M$3.98M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$21.98M$0
Common Stock$59K$55K$44K$38K$38K$37K$37K$32K$32K$26K$25K$1K$0
Retained Earnings-$445.9M-$326.18M-$261.18M-$393.51M-$347.1M-$275.91M-$312.65M-$269.05M-$160.71M-$90.02M-$49.82M-$20.83M-$3.83M
Comprehensive Income & Other$32K-$407K-$48K-$219K-$138K-$134K-$104K-$133K-$287K-$52K-$251K-$21.98M$0
Other Stockholders' Equity$641.93M$625.89M$497.46M$452.49M$442.12M$430.19M$412.12M$315.46M$294.73M$225.91M$218.87M$21.98M$0
Total Equity$196.08M$299.76M$236.32M$59.02M$95.06M$154.32M$99.51M$46.45M$134.05M$135.92M$169.07M$1.15M-$3.83M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$252.28M$393.05M$351.28M$159.36M$193.85M$261.58M$354.76M$177.03M$184.48M$189.57M$229.46M$11.5M$149K
Supplementary Data
Total Debt$36.5M$43.73M$20.29M$23.13M$44.18M$47.61M$34.17M$0$0$0$0$6.3M$2.93M
Net Debt-$28.8M-$27.64M-$48.51M-$75.83M-$73.25M-$56.83M-$51.87M-$46.86M-$31.53M-$36.64M-$31.31M-$730K$2.79M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$119.72M-$65M$132.33M-$46.41M-$71.2M$36.74M-$43.6M-$88.29M-$70.7M-$40.19M-$29.67M-$16.32M-$7.67M
Depreciation & Amortization$4.06M$4.73M$4.44M$6.19M$5.17M$3.82M$2.77M$2.12M$1.59M$612K$600K$184K$7.53M
Deferred Income Tax$0$0$0$0$0$0$0-$2.16M-$24K$696K$452K$0$0
Stock-Based Compensation$14.79M$14.79M$11.15M$9.34M$11.32M$14.93M$15.64M$15.71M$9.24M$6.31M$4.03M$425K$0
Changes in Working Capital:
  Accounts Receivable$268K$81.31M-$83.23M$475K$7.28M$10.48M-$18.5M$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$1.02M$2.39M-$962K$1.99M-$60K-$3.44M$2.6M-$282K$470K-$62K-$942K$604K$0
  Other Working Capital-$30.05M-$48.84M$17.64M$18M-$3.93M-$151.59M$94.34M$55.66M-$2.6M-$12.79M$57.08M-$127K$182K
Total Working Capital Change-$28.76M$34.86M-$66.56M$20.47M$3.29M-$144.54M$78.44M$55.38M-$2.13M-$12.85M$56.14M$477K$182K
Other Non-Cash Items-$2.83M-$4.68M-$3.45M-$2.11M-$2.11M-$7.67M-$4.58M$1.36M$674K$2.94M$9.75M$3.31M-$5.5M
Net Cash from Operating-$132.47M-$15.31M$77.92M-$12.51M-$53.52M-$96.72M$48.67M-$15.89M-$61.35M-$42.48M$41.3M-$11.92M-$5.45M
Investing Activities
Capital Expenditures-$2.6M-$3.52M-$3.26M-$2.49M-$1.61M-$12.1M-$7.72M-$4.3M-$3.98M-$5.03M-$1.03M-$2.99M$0
Acquisitions$0$0$138.39M$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$133.93M-$465.69M-$223.97M-$54.85M-$15.12M-$70.4M-$494.23M-$333.23M-$147.3M-$112.35M-$220.4M$0$0
Sales of Investments$261.97M$374.35M$85.58M$50M$82.63M$195.5M$411.3M$364M$147.6M$165.1M$26.66M$0$0
Other Investing Activities$0$0-$138.39M$0$0$0$172K$30.77M$304K-$421K-$193.74M-$314K$0
Net Cash from Investing$125.45M-$94.86M-$141.64M-$7.34M$65.91M$113M-$90.48M$26.47M-$3.68M$47.3M-$194.77M-$3.3M$0
Financing Activities
Debt Repaid-------------
Common Stock Issuance$816K$114.02M$33.65M$1.11M$612K$0$77.62M$0$57.99M$0$104.78M$80K$0
Common Stock Repurchases$0$0$0$0$0$0$0$860K$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$3.16M$3.38M$4.75M$1.93M$514K-$31.81M$0$5.72M
Net Cash from Financing$816K$114.02M$33.65M$1.11M$612K$3.16M$80.99M$4.75M$59.92M$514K$177.74M$22.12M$5.72M
Forex Effect$0$0$0$264K$0-$1.04M$0$0$0$0$0$0$0
Net Change in Cash-$6.21M$3.85M-$30.08M-$18.47M$12.99M$18.4M$39.18M$15.33M-$5.11M$5.33M$24.27M$6.9M$270K
Supplementary Data
Operating Cash Flow-$132.47M-$15.31M$77.92M-$12.51M-$53.52M-$96.72M$48.67M-$15.89M-$61.35M-$42.48M$41.3M-$11.92M-$5.45M
Capital Expenditure-$2.6M-$3.52M-$3.26M-$2.49M-$1.61M-$12.1M-$7.72M-$4.3M-$3.98M-$5.03M-$1.03M-$2.99M$0
Free Cash Flow-$135.06M-$18.83M$74.66M-$15M-$55.13M-$108.81M$40.95M-$20.19M-$65.33M-$47.51M$40.27M-$14.91M-$5.45M
Cash at Beginning$74.24M$70.39M$100.47M$117.43M$104.44M$86.04M$47.59M$32.27M$36.64M$31.31M$7.04M$135K$0
Cash at End$68.04M$74.24M$70.39M$98.96M$117.43M$104.44M$86.78M$47.59M$31.53M$36.64M$31.31M$7.04M$270K